Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) EPS (Basic) (2016 - 2025)

Apyx Medical (APYX) has disclosed EPS (Basic) for 16 consecutive years, with -$0.03 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 72.73% year-over-year to -$0.03, compared with a TTM value of -$0.27 through Dec 2025, up 59.09%, and an annual FY2025 reading of -$0.27, up 59.09% over the prior year.
  • EPS (Basic) was -$0.03 for Q4 2025 at Apyx Medical, up from -$0.05 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.03 in Q2 2023 and bottomed at -$0.28 in Q4 2023.
  • Average EPS (Basic) over 5 years is -$0.13, with a median of -$0.12 recorded in 2021.
  • The sharpest move saw EPS (Basic) surged 81.25% in 2023, then plummeted 533.33% in 2024.
  • Year by year, EPS (Basic) stood at -$0.06 in 2021, then tumbled by 183.33% to -$0.17 in 2022, then crashed by 64.71% to -$0.28 in 2023, then surged by 60.71% to -$0.11 in 2024, then soared by 72.73% to -$0.03 in 2025.
  • Business Quant data shows EPS (Basic) for APYX at -$0.03 in Q4 2025, -$0.05 in Q3 2025, and -$0.09 in Q2 2025.